Pinz et al. [41, 42, 60] constructed antiCD4 CAR T cells anti-CD4-CAR-NK cells that eliminated specifically and robustly diverse ex vivo CD4 + human T-cell leukemia and lymphoma cell lines upon transfer of the these ex vivo expanded CAR T or NK cells in vivo. This evidence concerns the gene CD4 and lymphoma.